Psychotropic drugs and falls: New evidence pertaining to serotonin reuptake inhibitors

被引:16
|
作者
Sleeper, R
Bond, CA
Rojas-Fernandez, C
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Practice, Amarillo, TX 79106 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Practice, Lubbock, TX USA
来源
PHARMACOTHERAPY | 2000年 / 20卷 / 03期
关键词
D O I
10.1592/phco.20.4.308.34885
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Falls are a significant cause of fatal and nonfatal injuries in older persons. Risk factors include previous falls, several disease states, and certain drugs such as tricyclic antidepressants and antihypertensives. We conducted a MEDLINE search from January 1966-March 1999 to identify studies and review articles on the association of neuroleptics, benzodiazepines, and antidepressants with fall risk in older people. The focus was on the risk associated with serotonin reuptake inhibitor, biologic plausibility, and limitations of these studies. It was thought that the agents did not increase the risk of falls, although recent evidence suggests that this is not the case.
引用
收藏
页码:308 / 317
页数:10
相关论文
共 50 条
  • [1] Antimicrobial activity of psychotropic drugs -: Selective serotonin reuptake inhibitors
    Munoz-Bellido, JL
    Munoz-Criado, S
    Garcìa-Rodrìguez, JA
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 14 (03) : 177 - 180
  • [2] NEW ANTIDEPRESSANTS - THE SEROTONIN REUPTAKE INHIBITORS
    AWAD, AG
    PSYCHIATRIC JOURNAL OF THE UNIVERSITY OF OTTAWA-REVUE DE PSYCHIATRIE DE L UNIVERSITE D OTTAWA, 1987, 12 (01): : 31 - 34
  • [3] The new antidepressants - Selective serotonin reuptake inhibitors
    Labellarte, MJ
    Walkup, JT
    Riddle, MA
    PEDIATRIC CLINICS OF NORTH AMERICA, 1998, 45 (05) : 1137 - +
  • [4] Evidence into practice - Prescribing selective serotonin reuptake inhibitors
    Freemantle, N
    Mason, JM
    Watt, I
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1998, 14 (02) : 387 - 391
  • [5] Selective serotonin reuptake inhibitors in pediatric psychopharmacology: A review of the evidence
    Hammerness, PG
    Vivas, FM
    Geller, DA
    JOURNAL OF PEDIATRICS, 2006, 148 (02): : 158 - 165
  • [6] Are Selective Serotonin Reuptake Inhibitors Safe for Drivers? What is the Evidence?
    Ravera, Silvia
    Ramaekers, Johannes G.
    de Jong-van den Berg, Lolkje T. W.
    de Gier, Johan J.
    CLINICAL THERAPEUTICS, 2012, 34 (05) : 1070 - 1083
  • [7] Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors
    Healy, D
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2003, 72 (02) : 71 - 79
  • [8] Selective serotonin reuptake inhibitors and violence: a review of the available evidence
    Walsh, MT
    Dinan, TG
    ACTA PSYCHIATRICA SCANDINAVICA, 2001, 104 (02) : 84 - 91
  • [9] In vitro antifungal effect of serotonin reuptake inhibitors in the combination with antifungal drugs
    Jilek, P.
    MYCOSES, 2011, 54 : 171 - 171
  • [10] Using Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Critical Care: A Systematic Review of the Evidence for Benefit or Harm
    Kelly, John M.
    Rubenfeld, Gordon D.
    Masson, Neil
    Min, Arimie
    Adhikari, Neill K. J.
    CRITICAL CARE MEDICINE, 2017, 45 (06) : E607 - E616